Dementia-related behavioural problems are common and debilitating. The assessment and management of these problems can be challenging.
Lack of adherence is a major reason for the failure of medical therapies and is an especially important and sometimes underappreciated issue for the growing number of people with dementia.
Cholinesterase inhibitors are a treatment option for most people with Alzheimer’s disease of mild to moderate severity.

